Kosaka, Yumi
Kawaoka, Tomokazu
Ogawa, Yutaro
Amioka, Kei
Naruto, Kensuke
Yoshikawa, Yuki
Ando, Yuwa
Suehiro, Yosuke
Yamaoka, Kenji
Fujii, Yasutoshi
Uchikawa, Shinsuke
Ono, Atsushi
Yamauchi, Masami
Imamura, Michio
Chosa, Keigo
Awai, Kazuo
Nagata, Yasushi
Chayama, Kazuaki
Aikata, Hiroshi https://orcid.org/0000-0002-3409-2156
Article History
Received: 14 May 2021
Accepted: 11 July 2021
First Online: 21 July 2021
Declarations
:
: Kazuaki Chayama has received honoraria from Bristol-Myers Squibb, MSD K.K., AbbVie Inc., Gilead Sciences, Dainippon Sumitomo Pharma and Mitsubishi Tanabe and research funding from Dainippon Sumitomo Pharma, MSD K.K, AbbVie Inc, Eisai, Toray, Otsuka, Chugai, Takeda, Roche, Mitsubishi Tanabe and Bristol-Byers Squibb. Michio Imamura has received research funding from Bristol-Myers Squibb. Other authors declare no competing interests.
: All procedures followed have been performed in accordance with the ethical standards laid down in the 1964 Declaration of Helsinki and its later amendments.
: Informed consent was obtained from all patients for being included in the study.